These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26864167)

  • 21. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
    Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
    Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accessibility of standardized information of a national colorectal cancer screening program for low health literate screening invitees: A mixed method study.
    Fransen MP; Dekker E; Timmermans DRM; Uiters E; Essink-Bot ML
    Patient Educ Couns; 2017 Feb; 100(2):327-336. PubMed ID: 27613567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
    Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
    Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.
    Benito L; Farre A; Binefa G; Vidal C; Cardona A; Pla M; García M
    Cancer Causes Control; 2018 Jan; 29(1):103-114. PubMed ID: 29170881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician counseling for colorectal cancer screening: impact on patient attitudes, beliefs, and behavior.
    Fenton JJ; Jerant AF; von Friederichs-Fitzwater MM; Tancredi DJ; Franks P
    J Am Board Fam Med; 2011; 24(6):673-81. PubMed ID: 22086810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
    Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
    Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the information needs of lung cancer screening participants: a qualitative study.
    Ruparel M; Quaife S; Baldwin D; Waller J; Janes S
    BMJ Open Respir Res; 2019; 6(1):e000448. PubMed ID: 31803474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambivalence and its influence on participation in screening for colorectal cancer.
    Oster C; Zajac I; Flight I; Hart E; Young GP; Wilson C; Turnbull D
    Qual Health Res; 2013 Sep; 23(9):1188-201. PubMed ID: 23917801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Knowledge, beliefs and attitudes of the Roma population regarding colorectal cancer screening].
    Santiago-Portero MC; Gómez-García JM; Reig-Gómez H; Oltra-Durá T; Gascón-Cánovas JJ
    Gac Sanit; 2018; 32(1):11-17. PubMed ID: 29157950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in attitudes impeding colorectal cancer screening.
    Ritvo P; Myers RE; Paszat L; Serenity M; Perez DF; Rabeneck L
    BMC Public Health; 2013 May; 13():500. PubMed ID: 23706029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study.
    James LJ; Wong G; Craig JC; Ju A; Williams N; Lim WH; Cross N; Tong A
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):568-576. PubMed ID: 28153937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
    Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
    Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trust, choice and obligation: a qualitative study of enablers of colorectal cancer screening in South Australia.
    Ward PR; Coffey C; Meyer S
    Sociol Health Illn; 2015 Sep; 37(7):988-1006. PubMed ID: 25912247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the Transtheoretical Model of Behaviour Change to describe readiness to rescreen for colorectal cancer with faecal occult blood testing.
    Duncan A; Turnbull D; Gregory T; Cole SR; Young GP; Flight I; Wilson C
    Health Promot J Austr; 2012 Aug; 23(2):122-8. PubMed ID: 23088473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'I've always done what I was told by the medical people': a qualitative study of the reasons why older adults attend multifactorial falls risk assessments mapped to the Theoretical Domains Framework.
    Racine E; Soye A; Barry P; Cronin F; Hosford O; Moriarty E; O'Connor KA; Turvey S; Timmons S; Kearney PM; McHugh SM
    BMJ Open; 2020 Feb; 10(2):e033069. PubMed ID: 32075829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of people's values and preferences for colorectal cancer screening participation.
    Fritzell K; Stake Nilsson K; Jervaeus A; Hultcrantz R; Wengström Y
    Eur J Public Health; 2017 Dec; 27(6):1079-1084. PubMed ID: 28160484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.